A.C. Pharma SRL
The score of A.C. Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -86 % Total assets -53 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
A.C. Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −74,212 € | ||||
| Equity | 43,466 € | ||||
| Cash | 51,721 € | ||||
| EBITDA | −66,364 € | ||||
| Total assets | 262,678 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 19 Nov 2024
- Year ended 31 Dec 2022filed on 25 Mar 2024
- Year ended 31 Dec 2021filed on 17 Aug 2023
A.C. Pharma's financial analysis
- Solvency16.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of A.C. Pharma
A.C. Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0633.801.067
- VAT number
- BE0633801067
- Peppol
- Registered · 0208:0633801067 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jul 2015
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
A.C. Pharma (SRL) has been based in Anderlecht since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 74,212 € and equity of 43,466 €; its revenue is not published. Its solvency stands at 16.5%, below the median of its sector (37.8%).
Companies similar to A.C. Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie d'Aumale Retail sale of pharmaceutical products Anderlecht · balance sheet 264,121 €
- Apotheek van het Museum Retail sale of pharmaceutical products Antwerp · balance sheet 262,357 €
- Apoteek Brichau Retail sale of pharmaceutical products Halle · balance sheet 263,690 €
- Atouphar Retail sale of pharmaceutical products Flémalle · balance sheet 260,410 €
- Tripharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 266,344 €
- Apotheca Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 258,897 €
- Linda Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet 258,710 €
- Yasmin Libbrecht Retail sale of pharmaceutical products Antwerp · balance sheet 258,250 €
Frequently asked questions about A.C. Pharma
What is the revenue of A.C. Pharma?
A.C. Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of A.C. Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0633801067 for A.C. Pharma, if the company is VAT-registered. Its company number (CBE) is 0633.801.067.
Where is the registered office of A.C. Pharma?
According to the CBE register, the registered office of A.C. Pharma is in 1070 Anderlecht.
What is the equity of A.C. Pharma?
At the close of the 2025 financial year, the equity of A.C. Pharma amounts to 43,466 €, a solvency of 16.5% of total assets.
Who manages A.C. Pharma?
The register lists 1 active mandates at A.C. Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of A.C. Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →